Free tool
FAERS Monitor: Ella
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022474 or its brand name (Ella, Ulipristal Acetate). Reports on generic versions are filed under their own applications.
Reports
512
Serious
456
89% of reports
Hospitalization
70
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- unintended pregnancy149
- abortion spontaneous108
- vaginal haemorrhage74
- drug ineffective54
- nausea39
- pregnancy after post coital contraception36
- abdominal pain28
- headache27
- dizziness26
- exposure during pregnancy24
- maternal exposure during pregnancy22
- abortion induced21
- vomiting19
- back pain17
- fatigue17
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2011 | 3 |
| 2012 | 35 |
| 2013 | 12 |
| 2014 | 17 |
| 2015 | 18 |
| 2016 | 40 |
| 2017 | 72 |
| 2018 | 60 |
| 2019 | 35 |
| 2020 | 23 |
| 2021 | 21 |
| 2022 | 41 |
| 2023 | 43 |
| 2024 | 33 |
| 2025 | 36 |
| 2026 | 23 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,647 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pregnancy after post coital contraceptionSignal | 36 | 665.3 | 484.2 | 22,853 |
| unintended pregnancySignal | 149 | 594.2 | 518.4 | 86,442 |
| abortion spontaneousSignal | 108 | 111.0 | 93.9 | 11,657 |
| abortion inducedSignal | 21 | 91.8 | 60.4 | 1,794 |
| vaginal haemorrhageSignal | 74 | 70.2 | 56.8 | 4,977 |
| exposure during pregnancySignal | 24 | 15.9 | 10.7 | 320 |
| maternal exposure during pregnancySignal | 22 | 10.1 | 6.7 | 173 |
| abdominal painSignal | 28 | 4.9 | 3.4 | 85 |
| back painSignal | 17 | 3.0 | 1.9 | 21 |
| dizzinessSignal | 26 | 2.1 | 1.5 | 15 |
| nauseaSignal | 39 | 2.0 | 1.5 | 20 |
| headache | 27 | 1.8 | 1.2 | 9 |
| drug ineffective | 54 | 1.7 | 1.3 | 15 |
| vomiting | 19 | 1.7 | 1.1 | 4 |
| fatigue | 17 | 0.9 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.